Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mira Ayoub"'
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)
Abstract Background Caudal regression syndrome is a rare complex congenital anomaly with reduced penetrance and phenotypic variability characterized by osseous defects of the caudal spine, lower limb anomalies, and accompanying genitourinary, gastroi
Externí odkaz:
https://doaj.org/article/30c4df0baa944299b50c6ff6d706be88
Autor:
Vivek Subbiah, Sara Ahmed, Christian Rolfo, Aung Naing, Joud Hajjar, Bettzy Stephen, Jordi Rodon Ahnert, Daniel D Karp, Rivka R Colen, Murat Ak, Mira Ayoub, Nabil Elshafeey, Priyadarshini Mamindla, Pascal O Zinn, Chaan Ng, Raghu Vikram, Spyridon Bakas, Christine B Peterson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
The need to identify biomarkers to predict immunotherapy response for rare cancers has been long overdue. We aimed to study this in our paper, ‘Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers’. In t
Externí odkaz:
https://doaj.org/article/8c521476fa4b4f408e287c5dfc55f7d1
Publikováno v:
Advances in experimental medicine and biology. 1342
Immune therapeutics are revolutionizing cancer treatments. In tandem, new and confounding imaging characteristics have appeared that are distinct from those typically seen with conventional cytotoxic therapies. In fact, only 10% of patients on immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::36d14395a4416f30d355f90be87f0d9a
https://pubmed.ncbi.nlm.nih.gov/34972979
https://pubmed.ncbi.nlm.nih.gov/34972979
Autor:
Matthew Pease, Murat Ak, Mira Ayoub, Priyadarshini Mamindla, Abdallah Kamal, Vishal Peddagangireddy, Pascal O. Zinn, Fanny Moron, Rivka R. Colen
Publikováno v:
Neurosurgery. 68:81-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::788441e4f76b31149443c32e847b9d39
https://doi.org/10.1227/neu.0000000000001880_348
https://doi.org/10.1227/neu.0000000000001880_348
Autor:
Priyadarshini Mamindla, Jordi Rodon Ahnert, Joud Hajjar, Nabil Elshafeey, Christian Rolfo, Vivek Subbiah, Spyridon Bakas, Christine B. Peterson, Aung Naing, Pascal O. Zinn, Bettzy Stephen, Murat Ak, Raghu Vikram, Rivka R. Colen, Daniel D. Karp, Chaan Ng, Mira Ayoub, Sara Ahmed
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
The need to identify biomarkers to predict immunotherapy response for rare cancers has been long overdue. We aimed to study this in our paper, ‘Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers’. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f813a0c77dd8881d602b24d2e2248917
https://jitc.bmj.com/content/9/7/e003299.full
https://jitc.bmj.com/content/9/7/e003299.full
Autor:
Pascal O. Zinn, Bettzy Stephen, Priyadarshini Mamindla, Rivka R. Colen, Joud Hajjar, Sara Ahmed, Jordi Rodon Ahnert, Chaan Ng, Christian Rolfo, Nabil Elshafeey, Vivek Subbiah, Murat Ak, Spyridon Bakas, Christine B. Peterson, Raghu Vikram, Mira Ayoub, Aung Naing, Daniel D. Karp
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)
BackgroundWe present a radiomics-based model for predicting response to pembrolizumab in patients with advanced rare cancers.MethodsThe study included 57 patients with advanced rare cancers who were enrolled in our phase II clinical trial of pembroli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c90d29357addec6abcc6da7c4c69eae
http://europepmc.org/articles/PMC8051405
http://europepmc.org/articles/PMC8051405
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783030793074
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df7520951c4437ad089f3f7eeef6f3f4
https://doi.org/10.1007/978-3-030-79308-1_19
https://doi.org/10.1007/978-3-030-79308-1_19
Publikováno v:
Advances in experimental medicine and biology. 1244
Immune therapeutics are revolutionizing cancer treatments. In tandem, new and confounding imaging characteristics have appeared that are distinct from those typically seen with conventional cytotoxic therapies. In fact, only 10% of patients on immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32f646a4e6214946dea4653206b740f6
https://pubmed.ncbi.nlm.nih.gov/32301025
https://pubmed.ncbi.nlm.nih.gov/32301025